cagrisema cagrilintide semaglutide phase 3 results 2024 2025 Achieves 22.7% Weight Loss in REDEFINE 1 Trial Novo Nordisk's next-gen obesity drug

BioDrugs 29 (5), 301307

Dermal Melanocytosis

Hatori M, Vollmers C, Zarrinpar A, DiTacchio L, Bushong EA, Gill S, Leblanc M, Chaix A, Joens M, Fitzpatrick JAJ, Ellisman MH, Panda S (2012) Time-restricted feeding without reducing caloric intake prevents metabolic diseases in mice fed a high-fat diet

At Solas Health & Wellness in El Paso, peptide protocols are prescribed and monitored by Celeste Cisneros, FNP-BC after baseline labs and a full health evaluation

Switching concentrations mid-protocol It is common to switch semaglutide concentrations during treatment

The move comes as his administration seeks to impose tariffs on pharmaceutical imports that many experts have said could lead to drug shortages and price hikes